nach oben

Irish Journal of Medical Science (1971 -)

Erschienen in:

01.09.2010 | Original Article

Plasma ghrelin levels and polymorphisms of ghrelin gene in Chinese obese children and adolescents

verfasst von: J. F. Zhu, L. Liang, C. C. Zou, J. F. Fu

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Aim

To evaluate the role of fasting plasma ghrelin levels [ln(ghrelin)] and polymorphisms of ghrelin gene in Chinese obese children.

Methods

Genotyping for ghrelin polymorphism was performed in 230 obese and 100 normal weight children. Among them, plasma ghrelin levels were measured in 91 obese and 23 health subjects.

Results

(1) Bivariate correlation analysis showed the ln(ghrelin) was inversely correlated with abnormality of glucose metabolism (r = −0.240, P = 0.023). Stepwise multiple regression analysis showed that abnormality of glucose metabolism was an independent determinant of plasma ghrelin levels (P = 0.023). (2) There was no difference in frequency of Leu72Met polymorphisms between obese and control groups (36.09 vs. 41.00%).

Conclusion

Ghrelin is associated with obesity in childhood, especially associated with the glucose homeostasis. Lower ghrelin levels might be a result of obesity, but not a cause of obesity. The Leu72Met polymorphism of ghrelin gene is not associated with obesity and metabolic syndrome in Chinese children.

Kojima M, Hosoda H, Date Y et al (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656–660. doi:10.1038/45230 CrossRefPubMed

Papotti M, Ghe C, Cassoni P et al (2000) Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab 85:3803–3807. doi:10.1210/jc.85.10.3803 CrossRefPubMed

Volante M, Allia E, Gugliotta P et al (2002) Expression of ghrelin and GHS receptor by pancreatic islet cells and related endocrine tumours. J Clin Endocrinol Metab 87:1300–1308. doi:10.1210/jc.87.3.1300 CrossRefPubMed

Broglio F, Prodam F, Me E et al (2005) Ghrelin: endocrine, metabolic and cardiovascular actions. J Endocrinol Invest 28:23–25PubMed

Schmid DA, Held K, Ising M et al (2005) Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls. Neuropsychopharmacology 30:1187–1192. doi:10.1038/sj.npp.1300670 CrossRefPubMed

Allison KC, Ahima RS, O’Reardon JP et al (2005) Neuroendocrine profiles associated with energy intake, sleep, and stress in the night eating syndrome. J Clin Endocrinol Metab 90:6214–6217. doi:10.1210/jc.2005-1018 CrossRefPubMed

Cummings DE, Purnell JQ, Frayo RS et al (2001) A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714–1719. doi:10.2337/diabetes.50.8.1714 CrossRefPubMed

Heath RB, Jones R, Frayn KN et al (2004) Vagal stimulation exaggerates the inhibitory ghrelin response to oral fat in humans. J Endocrinol 180:273–281. doi:10.1677/joe.0.1800273 CrossRefPubMed

Beck B, Richy S, Stricker-Krongrad A (2003) Ghrelin and body weight regulation in the obese Zucker rat in relation to feeding state and dark/light cycle. Exp Biol Med (Maywood) 228:1124–1131

10.

Tang-Christensen M, Vrang N, Ortmann S et al (2004) Central administration of ghrelin and agouti-related protein (83–132) increases food intake and decreases spontaneous locomotor activity in rats. Endocrinology 145:4645–4652. doi:10.1210/en.2004-0529 CrossRefPubMed

11.

Wren AM, Seal LJ, Cohen MA et al (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992. doi:10.1210/jc.86.12.5992 CrossRefPubMed

12.

Wren AM, Small CJ, Abbott CR et al (2001) Ghrelin causes hyperphagia and obesity in rats. Diabetes 50:2540–2547. doi:10.2337/diabetes.50.11.2540 CrossRefPubMed

13.

Wang G, Lee HM, Englander E et al (2002) Ghrelin: not just another stomach hormone. Regul Pept 105:75–81. doi:10.1016/S0167-0115(02)00012-5 CrossRefPubMed

14.

Levin F, Edholm T, Ehrstrom M et al (2005) Effect of peripherally administered ghrelin on gastric emptying and acid secretion in the rat. Regul Pept 131:59–65. doi:10.1016/j.regpep.2005.06.001 CrossRefPubMed

15.

Lee HM, Wang G, Englander EW et al (2002) Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 143:185–190. doi:10.1210/en.143.1.185 CrossRefPubMed

16.

Arosio M, Ronchi CL, Gebbia C et al (2003) Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels. J Clin Endocrinol Metab 88:701–704. doi:10.1210/jc.2002-021161 CrossRefPubMed

17.

Ukkola O, Ravussin E, Jacobson P et al (2001) Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. J Clin Endocrinol Metab 86(8):3996–3999. doi:10.1210/jc.86.8.3996 CrossRefPubMed

18.

Hinney A, Hoch A, Geller F et al (2002) Ghrelin gene: identification of missense variants and a frameshift mutation in extremely obese children and adolescents and healthy normal weight students. J Clin Endocrinol Metab 87(6):2716–2719. doi:10.1210/jc.87.6.2716 CrossRefPubMed

19.

Korbonits M, Gueorguiev M, O’Grady E et al (2002) A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. J Clin Endocrinol Metab 87(8):4005–4008. doi:10.1210/jc.87.8.4005 CrossRefPubMed

20.

Vivenza D, Rapa A, Castellino N et al (2004) Ghrelin gene polymorphisms and ghrelin, insulin, IGF-I, leptin and anthropometric data in children and adolescents. Eur J Endocrinol 151(1):127–133. doi:10.1530/eje.0.1510127 CrossRefPubMed

21.

Vartiainen J, Kesaniemi YA, Ukkola O (2006) Sequencing analysis of ghrelin gene 5’ flanking region: relations between the sequence variants, fasting plasma total ghrelin concentrations, and body mass index. Metabolism 55(10):1420–1425. doi:10.1016/j.metabol.2006.06.014 CrossRefPubMed

22.

Kuzuya M, Ando F, Iguchi A et al (2006) Preproghrelin Leu72Met variant contributes to overweight in middle-aged men of a Japanese large cohort. Int J Obes Lond 30:1609–1614. doi:10.1038/sj.ijo.0803296 CrossRefPubMed

23.

Group of China Obesity Task Force (2004) Body mass index reference norm for screening overweight and obesity in Chinese children and adolescents. Clin J Epidemiol 25(2):97–102

24.

Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419. doi:10.1007/BF00280883 CrossRefPubMed

25.

WHO (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus (WHO/NCD/NCS/99.2). World Health Organization, Geneva

26.

Kim SY, Jo DS, Hwang PH et al (2006) Preproghrelin Leu72Met polymorphism is not associated with type 2 diabetes mellitus. Metabolism 55(3):366–370. doi:10.1016/j.metabol.2005.09.011 CrossRefPubMed

27.

Shiiya T, Nakazato M, Mizuta M et al (2002) Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87:240–244. doi:10.1210/jc.87.1.240 CrossRefPubMed

28.

Haqq AM, Farooqi IS, O’Rahilly S et al (2003) Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocrinol Metab 88:174–178. doi:10.1210/jc.2002-021052 CrossRefPubMed

29.

Tritos NA, Kokkinos A, Lampadariou E et al (2003) Cerebrospinal fluid ghrelin is negatively associated with body mass index. J Clin Endocrinol Metab 88:2943–2946. doi:10.1210/jc.2003-030300 CrossRefPubMed

30.

Leidy HJ, Gardner JK, Frye BR et al (2004) Circulating ghrelin is sensitive to changes in body weight during a diet and exercise program in normal-weight young women. J Clin Endocrinol Metab 89:2659–2664. doi:10.1210/jc.2003-031471 CrossRefPubMed

31.

Suematsu M, Katsuki A, Sumida Y et al (2005) Decreased circulating levels of active ghrelin are associated with increased oxidative stress in obese subjects. Eur J Endocrinol 153:403–407. doi:10.1530/eje.1.01977 CrossRefPubMed

32.

McLaughlin T, Abbasi F, Lamendola C et al (2004) Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J Clin Endocrinol Metab 89:1630–1635. doi:10.1210/jc.2003-031572 CrossRefPubMed

33.

Broglio F, Gianotti L, Destefanis S et al (2004) The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Clin Endocrinol (Oxf) 60:592–599. doi:10.1111/j.1365-2265.2004.02011.x CrossRef

34.

Misra M, Miller KK, Stewart V et al (2005) Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab 90:5082–5087. doi:10.1210/jc.2005-0512 CrossRefPubMed

35.

Nagaya N, Itoh T, Murakami S et al (2005) Treatment of cachexia with ghrelin in patients with COPD. Chest 128:1187–1193. doi:10.1378/chest.128.3.1187 CrossRefPubMed

36.

Soriano-Guillen L, Barrios V, Martos G et al (2004) Effect of oral glucose administration on ghrelin levels in obese children. Eur J Endocrinol 151:119–121. doi:10.1530/eje.0.1510119 CrossRefPubMed

37.

Wortley KE, Anderson KD, Garcia K et al (2004) Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA 101:8227–8232. doi:10.1073/pnas.0402763101 CrossRefPubMed

38.

Sun Y, Ahmed S, Smith RG (2003) Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23:7973–7981. doi:10.1128/MCB.23.22.7973-7981.2003 CrossRefPubMed

39.

Flanagan DE, Evans ML, Monsod TP et al (2003) The influence of insulin on circulating ghrelin. Am J Physiol Endocrinol Metab 284:E313–E316PubMed

40.

Mohlig M, Spranger J, Otto B et al (2002) Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. J Endocrinol Invest 25:RC36–RC38PubMed

41.

Spranger J, Ristow M, Otto B et al (2003) Post-prandial decrease of human plasma ghrelin in the absence of insulin. J Endocrinol Invest 26:RC19–RC22PubMed

42.

Schaller G, Schmidt A, Pleiner J et al (2003) Plasma ghrelin concentrations are not regulated by glucose or insulin: a double-blind, placebo-controlled crossover clamp study. Diabetes 52:16–20. doi:10.2337/diabetes.52.1.16 CrossRefPubMed

43.

Bing C, Ambye L, Fenger M et al (2005) Large-scale studies of the Leu72Met polymorphism of the ghrelin gene in relation to the metabolic syndrome and associated quantitative traits. Diabet Med 22(9):1157–1160. doi:10.1111/j.1464-5491.2005.01575.x CrossRefPubMed

Titel: Plasma ghrelin levels and polymorphisms of ghrelin gene in Chinese obese children and adolescents
verfasst von: J. F. Zhu
L. Liang
C. C. Zou
J. F. Fu
Publikationsdatum: 01.09.2010
Verlag: Springer-Verlag
Erschienen in: Irish Journal of Medical Science (1971 -) / Ausgabe 3/2010
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI: https://doi.org/10.1007/s11845-010-0494-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Aim

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2010

Recombinant activated factor VII to control life-threatening haemorrhagic radiation cystitis

Emergency percutaneous transcatheter embolisation of acute arterial haemorrhage

In memoriam: Professor John Feely

Five-year experience of critical incidents associated with patient-controlled analgesia in an Irish University Hospital

Effect of pulsed radiofrequency therapy on the suprascapular nerve in shoulder pain of various aetiology